studi
immunogen
dna
sarsvaccin
whole
kill
viru
whole
kill
dna
vaccin
combin
dna
vaccin
contain
plasmid
encod
sar
coronaviru
sarscov
protein
control
human
cmv
promot
intron
whole
kill
viru
vaccin
compris
sarscov
propag
cell
subsequ
inactiv
formul
aluminum
hydroxid
adjuv
mice
immun
twice
dna
vaccin
whole
kill
viru
elicit
higher
antibodi
respons
mice
immun
three
time
dna
vaccin
whole
kill
viru
vaccin
mice
immun
twice
whole
kill
viru
vaccin
elicit
higher
antibodi
respons
mice
immun
three
time
dna
vaccin
whole
kill
viru
vaccin
howev
combin
vaccin
induc
thelper
type
immun
respons
whole
kill
viru
vaccin
induc
helper
type
immun
respons
result
demonstr
combin
dna
vaccin
whole
kill
viru
vaccin
use
enhanc
magnitud
chang
bia
immun
respons
sarscov
sever
acut
respiratori
syndrom
sar
latest
seri
emerg
infecti
diseas
acut
often
sever
respiratori
ill
emerg
southern
china
late
subsequ
spread
countri
earli
follow
year
sar
epidem
contain
case
death
addit
human
miseri
enorm
econom
damag
caus
agent
caus
agent
sar
identifi
new
type
coronaviru
sar
coronaviru
sarscov
sarscov
envelop
viru
posit
singlestrand
rna
genom
kb
length
consist
coronavirus
genom
encod
rnadepend
rna
polymeras
replic
associ
protein
end
viral
structur
protein
e
n
protein
sever
put
uncharacter
protein
end
recent
studi
indic
sarscov
spike
protein
express
noncleav
glycoprotein
appar
mass
kda
base
sequenc
comparison
sarscov
predict
class
fusion
protein
angiotensinconvert
enzym
report
function
receptor
sarscov
amino
acid
protein
requir
interact
receptor
suggest
protein
would
ideal
target
vaccin
prior
experi
infecti
diseas
control
suggest
vaccin
one
effect
measur
prevent
futur
sar
outbreak
develop
vaccin
sarscov
gene
express
differ
vector
system
find
date
identifi
signific
protect
antigen
among
sarscov
structur
protein
previous
yang
colleagu
describ
dna
plasmid
express
induc
sarscov
neutral
protect
immun
mice
describ
primeboost
combin
dna
vaccin
whole
kill
sarscov
vaccin
vaccin
combin
found
immunogen
mice
compar
dna
vaccin
whole
kill
viru
vaccin
alon
gene
cdna
strain
kindli
provid
dr
rachel
roper
univers
victoria
cterminu
spike
gene
fuse
amino
acid
sequenc
tag
facilit
subsequ
detect
gene
express
spike
gene
first
clone
vector
pbksii
restrict
enzym
nhei
xbai
step
clone
allow
us
insert
spike
gene
dna
vaccin
vector
pmasia
use
bamhi
site
result
construct
design
fig
plasmid
construct
character
restrict
digest
purifi
endofre
plasmid
maxi
kit
qiagen
stock
sarscov
obtain
dr
booth
nation
microbiolog
laboratori
winnipeg
manitoba
viru
passag
three
time
cell
obtain
sourc
use
stock
experi
prepar
titrat
plaqu
assay
found
contain
pfuml
confluent
monolay
cell
grown
fetal
bovin
serum
fb
infect
stock
sarscov
multipl
pfucel
infect
cell
lysat
harvest
h
post
infect
time
yield
viru
shown
maxim
cell
fraction
collect
centrifug
resuspend
trisbuff
salin
ph
subject
three
freezethaw
cycl
recentrifug
supernat
fraction
pool
medium
fraction
load
solut
sorbitol
tri
buffer
salin
ultracentrifug
sw
rotor
rpm
h
c
pellet
resuspend
trisbuff
salin
pool
final
volum
ml
ml
origin
cultur
supernat
purifi
viru
prepar
inactiv
addit
l
betapropiolacton
solut
tri
ph
ml
viru
ml
mem
ad
ph
indic
prepar
kept
c
mix
hourli
basi
first
h
naoh
ad
ph
becom
acid
h
prepar
place
c
water
bath
indic
color
monitor
ph
adjust
everi
min
two
independ
perform
immun
studi
experi
conduct
femal
balbc
mice
immun
group
five
mice
per
group
experiment
design
studi
summar
tabl
immun
given
subcutan
experi
finish
day
experi
day
experi
confirm
express
spike
gene
vitro
cell
transfect
g
plasmid
express
spike
gene
empti
vector
pmasia
togeth
fugen
reagent
roch
cell
lyse
mm
hepe
buffer
proteas
inhibitor
cocktail
roch
cell
lysat
clear
centrifug
protein
concentr
determin
bradford
assay
western
blot
g
protein
subject
electrophoresi
polyacrylamid
gel
transfer
onto
pvdf
membran
amersham
membran
probe
monoclon
antibodi
invitrogen
hrpconjug
secondari
antibodi
specif
protein
membran
visual
eclplu
reagent
amersham
antibodi
titer
serum
immun
mice
measur
elisa
ninetysixwel
plate
coat
overnight
mlwell
gml
purifi
recombin
spike
protein
plate
wash
five
time
phosphat
buffer
salin
pb
contain
sera
serial
dilut
pb
contain
gelatin
ad
respect
well
incub
plate
wash
dilut
biotinyl
goat
antimous
antibodi
caltag
laboratori
ad
incub
plate
wash
dilut
alkalin
phosphatas
conjug
streptavidin
jackson
immunoresearch
ad
incub
plate
wash
eight
time
develop
sigma
stop
hcl
analyz
nm
use
elisa
plate
reader
sera
test
antibodi
sarscov
standard
viru
neutral
test
serum
heat
c
min
duplic
serial
dilut
incub
pfu
sarscov
h
ad
monolay
cell
cultur
examin
h
characterist
cpe
dilut
one
cpe
first
note
deem
antibodi
titr
assay
refer
serum
design
sar
convalesc
patient
use
posit
control
serum
subject
infect
sar
neg
control
cellular
immun
respons
sarscov
assess
elispot
assay
use
murin
splenocyt
unifilt
plate
coat
overnight
mlwell
gml
rat
antimous
bd
pharmingen
wash
rpmi
life
technolog
contain
fb
incub
triplic
splenocyteswel
ml
rpmi
media
fb
contain
gml
synthet
peptid
sequenc
four
uniqu
synthet
peptid
deriv
sarscov
protein
apnytqhtssmrgvyypdeifrsdt
tgnynykyrylrhgklrpf
ltpsskrfqpfqqfgrdvsdftdsvrdpk
lqpeldsfkeeldkyfknht
h
incub
c
co
incub
plate
wash
five
time
pb
contain
incub
overnight
c
biotinyl
rat
antimous
antibodi
bd
pharmingen
mlwell
gml
wash
pb
contain
plate
incub
h
dilut
streptavidinalkalin
phosphatas
jackson
immunoresearch
eight
wash
water
plate
develop
sigma
fast
phosphatenitro
blue
tetrazolium
develop
stop
wash
tap
water
plate
airdri
read
aid
microscop
evalu
protein
express
dna
vaccin
vector
cell
h
posttransfect
western
blot
analysi
use
antibodi
epitop
protein
detect
cell
lysat
doublet
estim
upper
band
molecular
weight
kda
lysat
boil
analyz
reduc
sdspage
condit
fig
lane
experi
indic
fulllength
sarscov
protein
express
mammalian
cell
two
differ
glycosyl
form
centrifug
aliquot
resuspend
pellet
examin
electron
microscopi
evid
spike
protein
viru
subject
sdspage
western
blot
sar
patient
convalesc
serum
test
infect
tcid
cell
monolay
microtitr
plate
accept
lot
purifi
viru
titr
tcid
ml
display
promin
band
correspond
kda
sdspage
western
blot
abund
viru
well
defin
spike
protein
evid
em
fig
inactiv
procedur
aliquot
test
infect
cell
cultur
sdspage
western
blot
accept
prepar
display
promin
band
correspond
kda
sdspage
western
blot
evid
infect
data
shown
first
experi
two
group
balbc
mice
prime
dna
vaccin
boost
dna
whole
kill
sarscov
vaccin
third
group
mice
immun
whole
kill
sarscov
vaccin
without
dna
prime
second
experi
balbc
mice
immun
twice
fourweek
interv
whole
kill
sarscov
vaccin
follow
immun
humor
immun
respons
assess
sera
elisa
vitro
viru
neutral
tabl
result
repres
averag
triplic
well
express
mean
standard
error
increas
antibodi
titer
sarscov
protein
found
mice
receiv
combin
vaccin
fig
statist
analysi
use
individu
titer
indic
mean
titer
obtain
combin
vaccin
significantli
higher
obtain
immun
dna
vaccin
one
immun
whole
kill
viru
vaccin
p
student
ttest
mice
immun
vaccin
combin
elicit
significantli
p
higher
neutral
antibodi
titer
fig
mice
immun
dna
vaccin
whole
kill
viru
vaccin
result
indic
immun
vaccin
combin
power
gener
humor
immun
respons
compar
respons
induc
dna
vaccin
comparison
whole
kill
viru
vaccin
vaccin
combin
superior
one
inject
whole
kill
viru
vaccin
elicit
respons
compar
two
inject
whole
kill
viru
vaccin
fig
determin
presenc
sspecif
cellular
immun
respons
splenocyt
isol
vaccin
control
mice
antigenspecif
respons
measur
elispot
shown
fig
mice
immun
combin
vaccin
develop
significantli
higher
number
sspecif
spot
compar
mice
receiv
dna
vaccin
alon
control
mice
develop
elispot
respons
found
produc
cell
splenocyt
immun
mice
result
suggest
vaccin
regiment
gener
immun
respons
sinc
secret
cell
contrast
two
inject
whole
kill
vaccin
induc
produc
cell
produc
cell
fig
indic
immun
respons
first
global
sar
outbreak
control
howev
origin
viru
remain
obscur
therefor
vigil
must
maintain
appropri
control
measur
must
avail
implement
event
reoccur
previou
experi
control
viral
diseas
suggest
vaccin
may
one
effect
measur
prevent
sar
recent
studi
identifi
protein
one
induc
signific
sarscov
neutral
sarscov
gene
express
differ
vector
system
ultim
goal
develop
sarscov
vaccin
two
report
plasmid
dna
express
sarscov
gene
fragment
use
develop
dna
vaccin
author
demonstr
neutral
antibodi
product
protect
antisarscov
immun
mice
anoth
studi
tang
colleagu
develop
inactiv
sarscov
vaccin
prepar
whole
viru
demonstr
high
level
neutral
antibodi
mice
immun
vaccin
present
studi
compar
dna
whole
kill
sarscov
vaccin
alon
combin
dna
vaccin
vector
contain
fulllength
sarscov
gene
control
power
human
cmv
promot
intron
show
previous
human
cmv
promot
intron
improv
vitro
gene
express
sequenc
protein
suggest
contain
ntermin
signal
sequenc
ctermin
hydrophob
membraneanchor
domain
use
fulllength
protein
shown
protein
anchor
cell
surfac
gener
better
immun
respons
secret
version
protein
find
suggest
protein
express
transfect
cell
singl
uncleav
polypeptid
two
differenti
glycosyl
form
agreement
recent
publish
data
result
clearli
demonstr
combin
vaccin
immunogen
mice
dna
vaccin
alon
higher
antibodi
respons
compar
dna
vaccin
whole
kill
viru
vaccin
alon
well
higher
cellmedi
respons
compar
dna
vaccin
alon
elicit
although
vaccin
strategi
consist
prime
dna
vaccin
follow
boost
protein
vaccin
describ
virus
studi
suggest
strategi
use
vaccin
sarscov
well
combin
vaccin
dna
vaccin
induc
immun
respons
two
inject
whole
kill
vaccin
induc
respons
fig
shown
previous
aluminum
adjuv
skew
immun
respons
toward
respons
dna
vaccin
enhanc
tcell
immun
respons
immun
associ
immun
respons
thought
essenti
control
intracellular
pathogen
therefor
chang
bia
immun
respons
may
attract
featur
vaccin
combin
strategi
understand
immun
sarscov
vital
develop
effect
vaccin
take
consider
clinic
evid
incub
period
sar
short
day
week
patient
appear
recov
within
short
time
persist
latent
infect
reason
conclud
neutral
antibodi
may
play
import
role
prevent
sarscov
infect
also
shown
laboratori
anim
neutral
antibodi
play
import
role
prevent
viral
replic
protect
also
achiev
administr
sspecif
monoclon
antibodi
howev
contribut
tcell
immun
exclud
report
appar
deplet
cell
occur
earli
sarscov
infect
patient
gradual
increas
normal
level
observ
patient
recov
moreov
tcell
epitop
sarscov
protein
elicit
specif
tcell
immun
respons
patient
recov
sar
therefor
gener
humor
cellular
immun
respons
would
benefici
vaccin
sar
